A detailed history of Torren Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Torren Management, LLC holds 719 shares of CORT stock, worth $54,313. This represents 0.01% of its overall portfolio holdings.

Number of Shares
719
Holding current value
$54,313
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026

BUY
$71.1 - $90.32 $51,120 - $64,940
719 New
719 $25 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Torren Management, LLC Portfolio

Follow Torren Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torren Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torren Management, LLC with notifications on news.